KRM22

KRM · AIM · Technology · mcap £20m · 34.5p 2 open situations →

Beta Briefing, track record and signals & risks are not ready for KRM22 yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation

dots = announcements

2026 Slower 2026 sales conversion 1 director buying

Open · 2

Upgrade / downgrade cycle

Slower 2026 sales conversion

H1 new ARR £0.3m; post-period ARR £8.4m

Slow 2026 sales conversion has been flagged since May. H1 new contracted ARR was £0.3m against £1.0m a year earlier. Post-period wins from a Limits Manager expansion and a new Risk Manager client lifted ARR to £8.4m. Management keeps confidence in market forecasts.

H1 new ARR: £0.3m versus £1.0m in H1 2025
ARR at 30 June: £7.9m, up 10% year on year
ARR at report date: £8.4m at current FX rates
Sales cycles: Prolonged, per outlook statement

Next: ARR growth and delivery against market forecasts in H2

30 Sep 2026 H1 new ARR £0.3m; post-period ARR £8.4m
23 Sep 2026 New win; ARR £8.4m versus £7.9m at H1
29 Jul 2026 Delays persist; H1 net new ARR only £0.3m
13 May 2026 Only £0.1m new ARR signed in 2026

Open the full view – chart and every step →

Insider conviction

1 director buying

£25k in 1 buy

20 Aug 2026 Garry Jones £25k

Open the full view – chart and every step →

Company filings. Not investment advice.